KRISTIN DYE: Open Payments
NPI 1770834376 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 81 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $713 · 2025 $1,741
Food & beverage: $1,741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $489 |
| Amgen Inc. | 13 | $255 |
| Janssen Biotech, Inc. | 11 | $230 |
| PFIZER INC. | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 2 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| UCB, Inc. | 2 | $60 |
| Aurinia Pharma U.S., Inc. | 2 | $59 |
| Invivyd Inc | 2 | $56 |
| Alexion Pharmaceuticals, Inc. | 2 | $46 |
Products named: RINVOQ, SKYRIZI, TREMFYA, KRYSTEXXA, XELJANZ, SAPHNELO, COSENTYX, Bimzelx.
Industry payments across MD — which companies pay providers there.
